Inactive

Sources Sought Notice NIST-MML-20-SS02 Project Title: ACQUISITION, POOLING, AND VIALING OF HUMAN SERUM MATERIALS FOR CANDIDATE RM 2922 - CARDIAC TROPONIN I IN HUMAN SERUM This is a Sources Sought Noti... Sources Sought Notice NIST-MML-20-SS02 Project Title: ACQUISITION, POOLING, AND VIALING OF HUMAN SERUM MATERIALS FOR CANDIDATE RM 2922 - CARDIAC TROPONIN I IN HUMAN SERUM This is a Sources Sought Notice ONLY. Requests for copies of a solicitation will not receive a response. This Notice is for planning purposes only and is not a Request for Proposal or Request for Quotation or an obligation on the part of the National Institute of Standards and Technology (NIST) for conducting a follow-on acquisition. NIST does not intend to award a contract on the basis of this Notice, or otherwise pay for the information requested. No entitlement or payment of direct or indirect costs or charges by NIST will arise as a result of submission of responses to this Notice and NIST use of such information. NIST recognizes that proprietary components, interfaces and equipment, and clearly mark restricted or proprietary components, interfaces and equipment, and clearly mark restricted or proprietary data and present it as an addendum to the non-restricted/non-proprietary information. In the absence of such identification, NIST will assume to have unlimited rights to all technical data in the information paper. NO SOLICITATION DOCUMENTS EXIST AT THIS TIME. Requirement: NIST is seeking information on contractors who can provide the following: The National Institute of Standards and Technology in Gaithersburg, MD is seeking vendors capable of providing human serum materials for a reference material (RM). Requirements will be based on specifications provided by NIST for 1) collection and storage of normal human serum samples, and 2) pooling of normal human serum samples and separate pooling of NIST-provided human disease serum samples, followed by blending, aliquoting, and bottling of mixed normal-and-disease serum pools. Final aliquots from this effort will be provided to NIST for sale as NIST RM 2922 - cTnI in Human Serum. RM 2922 will be a four (4)-component material with varying target cTnI concentrations, based on value-assignments and specifications from NIST. Interested parties shall describe the capabilities of their organization as it relates to the service described above. NIST anticipates issuing a Request for Quotation in the first quarter of FY2020, and awarding a contract no later than the second quarter of FY2020. NIST is seeking responses from all responsible sources, including large and small businesses. The small business size standard associated with the NAICS code for this effort 325413, is 1,250 employees. Please include your company's size classification and socio-economic status in any response to this notice. After results of this market research are obtained and analyzed, NIST may conduct a competitive procurement and subsequently award a contract. Companies that can provide such services are requested to email a written response describing their abilities to donald.graham@nist.gov no later than the response date for this sources sought notice. The following information is requested to be provided as part of the response to this sources sought notice: 1. Name, Address, DUNS number, CAGE code, and point of contact information of your company. 2. Any information on the company's small business certifications, if applicable. 3. Description of your company's capabilities as they relate to the services described in this notice. 4. A description of your company's previous experience providing the services described in this notice. 5. Indication of whether the services described in this notice are currently offered via your company's GSA Federal Supply Schedule (FSS) contracts, Government-wide Acquisition Contracts (GWACs), or other existing Government-wide contract vehicles; and, if so, the contract number(s) for those vehicles. 6. Any other relevant information that is not listed above which the Government should consider in finalizing its market research. Responses are limited to a total of twelve (12) pages. The responses must be in MS Word format. Pages shall be 8½-inch x 11-inch, using Times New Roman 11 Point Font. Each page shall have adequate margins on each side (at least one inch) of the page. Header/footer information (which does not include any information to be analyzed) may be included in the 1" margin space.